ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Vildagliptin attenuates the development of CCl₄-induced liver fibrosis: associations with gut-liver axis modulation and LPS/notch-related signaling.
Aya M Eid et al.PubMed ↗Publisher ↗
No numbers read from the abstract.